Validating Product-Market Fit in Life Sciences: Why Voice of Customer Is Non-Negotiable

Many Life Sciences companies launch products with strong clinical data but weak commercial traction. The missing link is almost always a rigorous Voice of Customer process — and it needs to happen before you build your sales team.

The Problem with Assumptions

In Life Sciences, it's tempting to believe that a clinically superior product sells itself. The science is sound, the data is compelling, and the unmet need is real. Yet time and again, organizations miss revenue targets in the first 12–24 months post-launch — not because the product failed, but because the commercial strategy was built on assumptions rather than validated insights.

The most common assumption? That the people who will buy your product are the same people who will use it, and that both groups care about the same things.

They rarely do.

What Voice of Customer Actually Means

Voice of Customer (VOC) is not a survey. It's not a focus group. It's a structured, qualitative interview process designed to uncover the real decision-making criteria, workflow pain points, and adoption barriers that exist in your target market — before you invest in a full commercial launch.

Done well, VOC interviews answer questions like:

• Who actually makes the purchasing decision, and who influences it?
• What does the current workflow look like, and where does your product fit (or disrupt)?
• What objections will your sales team face, and how should they be addressed?
• Is your pricing model aligned with how customers think about value?
• Are you targeting the right market segment first?

These are not questions you can answer from a conference room in Madison, Wisconsin. They require direct, candid conversations with the clinicians, lab directors, procurement officers, and administrators who will interact with your product.

When to Do It

The ideal time for a VOC process is before you finalize your Go-to-Market plan — ideally 6–12 months before commercial launch for a new product, or immediately after missing a revenue target for an existing one.

For early-stage companies, VOC is often the difference between a successful Early Adopter program and a costly false start. For commercially launched organizations, it's the fastest way to diagnose why adoption is slower than projected.

What Good VOC Looks Like

A rigorous VOC process for a Life Sciences product typically includes:

1. **Stakeholder mapping** — Identifying all the roles involved in the decision and adoption process
2. **Interview guide development** — Crafting open-ended questions that surface real behavior, not hypothetical preferences
3. **15–20 structured interviews** — Across multiple institutions, geographies, and stakeholder types
4. **Thematic analysis** — Identifying patterns across interviews that reveal consensus and outliers
5. **Strategic synthesis** — Translating findings into concrete recommendations for positioning, targeting, and messaging

The output is not a report that sits on a shelf. It's a living input into your commercial strategy — one that should directly shape your sales playbook, your marketing messaging, and your pricing model.

The Cost of Skipping It

We've worked with organizations that launched without VOC and spent 18 months trying to figure out why their pipeline wasn't converting. In almost every case, the root cause was a mismatch between what the company thought customers valued and what customers actually valued.

The cost of a thorough VOC process is a fraction of the cost of a failed launch or a commercial team rebuild.

If you're preparing for a product launch or trying to understand why your current commercial strategy isn't working, VOC is the place to start.

*Monona Technical Resources provides Voice of Customer interview services as part of our Go-to-Market Strategy Development offering. Contact us to learn more.*